GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » EBITDA Margin %

FibroBiologics (FibroBiologics) EBITDA Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. FibroBiologics's EBITDA for the three months ended in Mar. 2024 was $-8.32 Mil. FibroBiologics's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, FibroBiologics's EBITDA margin for the quarter that ended in Mar. 2024 was 0.00%.


FibroBiologics EBITDA Margin % Historical Data

The historical data trend for FibroBiologics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics EBITDA Margin % Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
EBITDA Margin %
- - -

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of FibroBiologics's EBITDA Margin %

For the Biotechnology subindustry, FibroBiologics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where FibroBiologics's EBITDA Margin % falls into.



FibroBiologics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

FibroBiologics's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-15.901/0
= %

FibroBiologics's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-8.319/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics  (NAS:FBLG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


FibroBiologics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of FibroBiologics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines